Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d758be13e81bff57954d36379234dd7f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0004 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00 |
filingDate |
2007-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f00e134099d3f7662df478cca95c0d3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c5738e3aed7e7002206cb8db8dbc45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b723a5970169c25a07279fc09dc10e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efcfd120136d2f4ee6d89a98f64b4d0d |
publicationDate |
2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2056715-A2 |
titleOfInvention |
Functional assessment and treatment catheters and methods for their use in the lung |
abstract |
Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed. |
priorityDate |
2006-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |